RxDoctor Payments Data

Julia Gibson, PA

Physician Assistant · San Diego, CANPI 1104538537

Payments from drug & device makers

$1,999in general payments, 2019–2025

Across 59 payments — averaging $33.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$214
  • Exact Sciences$182
  • Stryker$165
  • Lilly USA, LLC$151
  • Gilead$126
  • Heartflow, Inc.$125
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$1,999100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,999 in reported general payments places this provider in the 80th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$13,608
Medicare patients
87
Services billed
181

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide22$20,169
Atorvastatin Calcium50$766
Rosuvastatin Calcium20$564
Levothyroxine Sodium26$361
Metformin Hcl ErMetformin Hcl13$323
Albuterol Sulfate HfaAlbuterol Sulfate16$303
Lisinopril26$281
Metformin Hcl29$266
Losartan Potassium35$263
Escitalopram Oxalate11$236
Simvastatin22$213
Omeprazole21$209
Amlodipine Besylate34$158
Alendronate Sodium12$155
Hydrochlorothiazide23$154

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$95$20,16922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,423 physician assistant providers in California.

Other physician assistant in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →